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Objective: To differentiate the human embryonic stem cells (hESCs) into the retinal pigment epithelium (RPE) in the defined culture condition 
and determine its therapeutic potential for the treatment of retinal degenerative diseases.
Methods: The embryoid bodies were formed from hESCs and attached on the matrigel coated culture dishes. The neural structures consisting 
neural precursors were selected and expanded to form rosette structures. The mechanically isolated neural rosettes were differentiated into 
pigmented cells in the media comprised of N2 and B27. Expression profiles of markers related to RPE development were analyzed by reverse 
transcription-polymerase chain reaction and immunostaining. Dissociated putative RPE cells (10
5 cells/5 µL) were transplanted into the subreti-
nal space of rat retinal degeneration model induced by intravenous sodium iodate injection. Animals were sacrificed at 1, 2, and 4 weeks after 
transplantation, and immnohistochemistry study was performed to verify the survival of the transplanted cells. 
Results: The putative RPE cells derived from hESC showed characteristics of the human RPE cells morphologically and expressed molecular mark-
ers and associated with RPE fate. Grafted RPE cells were found to survive in the subretinal space up to 4 weeks after transplantation, and the ex-
pression of RPE markers was confirmed with immunohistochemistry. 
Conclusion: Transplanted RPE cells derived from hESC in the defined culture condition successfully survived and migrated within subretinal 
space of rat retinal degeneration model. These results support the feasibility of the hESC derived RPE cells for cell-based therapies for retinal de-
generative disease. 
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Introduction
The retina is part of the central nervous system and plays the most 
important role in the visual pathway. In the retinal degenerative dis-
eases such as age-related macular degeneration and genetic retinal 
diseases like Stargardt disease, dysfunction and loss of retinal pig-
ment epithelium (RPE) are major pathologic changes leading to visu-
al loss [1]. The RPE is composed of a monolayer of pigmented cells 
that lies adjacent to photoreceptor outer segments and plays a cru-
cial role in retinal homeostasis. The RPE cells are critical for photore-
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ceptor survival, including nutrient and ion transport, light absorp-
tion, recycling of retina, and formation of blood-retinal barrier [2]. 
Consequently, RPE dysfunction leads to photoreceptor loss and sub-
sequent central visual loss. However, there is no radical therapeutic 
modality to recover damaged RPE or photoreceptor cells in retinal 
degenerative disease. To restore vision in these patients, one promis-
ing therapeutic strategy could be cell-based transplantation thera-
pies to replace damaged retinal cells with functioning cells [3-8].
Stem cells are ideal candidate donor source because of their capac-
ity to self-renew and generate multiple differentiated cell types. Un-
like tissue stem cells, human embryonic stem cells (hESC) retain un-
limited self-renewal potential and are expected to alleviate the prob-
lem of donor cell shortage for cell-replacement therapy [9]. Although 
photoreceptor differentiation from embryonic stem cell is crucial for 
the cell-based therapy of vision restoration, successful differentiation 
into functional photoreceptor has not yet been reported. On the oth-
er hand, several investigators have reported RPE differentiation from 
hESCs [6,10-16]. There is increasing evidence to suggest that RPE cells 
derived from hESCs are more akin to RPE cells than cell lines original-
ly created from human RPE tissue, when characterized in terms of 
morphology, gene expression, and immunohistochemical profile 
[6,10-12]. 
Recently we developed a new protocol to differentiate the hESC 
(SNUhES3) into putative RPE cells in the defined culture condition 
and confirmed the characteristics of RPE differentiation. In addition, 
we performed the subretinal transplantation of the differentiated 
RPE cells in a rat retinal degeneration model induced by sodium io-
date and investigated the survival and integration of the transplant-
ed cells. 
Methods
1. Cell culture and derivation of putative RPE cells
The hESC, SNUhES3 was maintained as described previously [17]. 
Undifferentiated hESC colonies were detached mechanically and cul-
tured in a bacterial dish for 7 days to form embryoid body (EB). For 
neural differentiation, cultured EBs (5 day-old) were attached on the 
matrigel-coated culture dishes and cultured to select the neural struc-
tures consisting neural precursors in media supplemented with 0.5% 
N2 for 5 days. The selected neural precursors were expanded to form 
rosette structures in the media with basic fibroblast growth factor 
(bFGF; #13256-029; Invitrogen, Carlsbad, CA, USA) and 1% N2 for sev-
en to ten days. These rosettes structures were isolated mechanically 
and reattached onto matrigel-coated culture dishes. To facilitate the 
differentiation of reattached cells toward RPE fate, bFGF was replaced 
by B27 (2%) from the expansion medium for RPE differentiation and 
expansion. The mechanically isolated rosettes were differentiated to 
pigmented cells, which were presumed to be RPE cells. 
2. Characterization of putative RPE cells
1) Immunocytochemistry
Pigmented cells were washed with phosphate-buffered saline (PBS) 
and fixed with 4% paraformaldehyde. After blocking overnight in 3% 
bovine serum albumin solution in PBS containing 0.1% Triton ×100, 
samples were incubated with primary antibodies overnight. Rabbit 
anti-tight junction protein ZO-1 (1:200, Zymed, South San Francisco 
CA, USA) and mouse anti-microphthalmia-associated transcription 
factor Mitf (1:200, Abcam, Cambridge, CB, UK) were primary anti-
bodies used for immunocytochemistry. Normal rabbit IgG (1:200, 
Zymed) or mouse IgG (1:200, Zymed) were used as negative control 
antibodies. To detect antibodies, Alexa Fluor 488 donkey anti-mouse 
and anti-rabbit IgG (1:200, Molecular Probes, Eugene, OR, USA) and 
Alexa Fluor 594 donkey anti-mouse and anti-rabbit IgG (1:200, Mo-
lecular Probes) were used, and the cell nuclei were counterstained 
with 4’6-diamidino-2-phenylindole (DAPI; 10 µg/mL, Sigma-Aldrich, 
St. Louis, MO, USA). 
2) Reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA was isolated from hESCs, EBs, putative RPE cells from me-
chanically isolated rosettes at day 5, 41 and 74 using TRIzol Reagent 
(Invitrogen, Carlsbad, CA, USA). cDNA synthesis was conducted using 
AMV RT and oligo-dT as a primer according to the manufacturer’s in-
structions (AccuPower RT PreMix; Bioneer, Daejeon, Korea). PCR am-
plification was performed with Taq Polymerase (Hipi Plus 5x PCR Pre-
mix; Elpis biotech, Daejeon, Korea) using a standard procedure. Val-
ues for each gene were normalized to expression levels of glyceral-
dehydes-3-phosphate dehydrogenase. PCR conditions were optimiz-
ed, and a linear amplification range was determined for each pair of 
primers by varying the annealing temperature and cycle numbers. 
Primers used for the reactions were Pax6, Mitf, bestrophin, and RPE65. 
The sequences of the primers are available on request. 
3. Subretinal implantation of putative RPE cells in sodium 
iodate induced rat retinal degeneration model 
A total of nine 6-week-old Sprague Dawley rats were used. The ani-
mals were treated according to the regulations in the ARVO State-
ment for the Use of Animals in Ophthalmic and Vision Research, and 
the study was approved by the IACUC of Seoul National University 
Hospital. The animals received a single intravenous injection of sterile 
1% NaIO3 diluted in saline through a caudal vein at a dose of 50 mg/
kg. Four days after administration, the animals were anesthetized 
with intramuscular injection of tiletamine/zolazepam and xylazine. 
The pupils were dilated with tropicamide 0.5% and phenylephrine 
hydrochloride (HCl) 2.5% eye drops, and topical anesthetic eye drops   http://dx.doi.org/10.5653/cerm.2011.38.4.216
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of proparacine HCl 0.5% were administered. Before implantation, pu-
tative RPE cells were incubated with DAPI (10 µg/mL) for 30 minutes, 
washed several times to remove DAPI in the media, and then dissoci-
ated by incubation for 5 minutes in 0.05% trypsin/0.1% ethylenedi-
aminetetraacetic acid at 37°C. Under visualization with an operating 
microscope, dissociated putative RPE cells (10
5 cells/5 µL) were in-
jected into the dorsal subretinal space via a transscleral approach us-
ing a 33-gauge needle attached to a Hamilton syringe. Immediately 
after injection, the fundus was examined and any animals with mas-
sive subretinal hemorrhage or vitreous hemorrhage were removed 
from the study. Cyclosporin A (210 mg/L, Cipol-N; Chong Kun Dang, 
Seoul, Korea) was administered into the drinking water from 1 day 
before transplantation until enucleation. 
Three animals were sacrificed at each of one, two, and four weeks 
after putative RPE cell transplantation. After enucleation, the eyes 
were rapidly frozen in embedding compound (FSC 22; Leica Micro-
systems, IL, USA). Cryostat sections were washed with PBS and incu-
bated in 3% bovine serum albumin solution in PBS containing 0.1% 
Triton ×100, followed by an overnight incubation in primary anti-
bodies. Anti-ZO-1, anti-RPE65, and anti-Bestrophin antibodies were 
used for immunohistochemistry. Alexa Fluor 488 donkey anti-mouse 
IgG (1:200) and Alexa Fluor 594 donkey anti-rabbit igG (1:200) were 
used to detect the primary antibodies. 
Results
1. Characterization of putative RPE cells
On light microscopic examination, differentiated cells from rosette 
showed hexagonal shape with monolayer structure on the culture 
dish, which is typical characteristic of the RPE cells. Figure 1A shows 
phase-contrast image of pigmented cells transferred on a cover glass 
on day 24 when the cells were cultured in N2 and B27 for RPE differ-
entiation. During the differentiation process of pigmented cells from 
rosettes, expression profiles of markers related to development and 
cellular function of RPE were analyzed by RT-PCR and immunocyto-
chemistry. 
RT-PCR showed the mRNA expression of Pax6 (early neural marker), 
Mitf (transcriptional factor in melanogenesis), bestrophin (RPE spe-
cific protein located in basolateral plasma membrane), and RPE65 
(retinoid recycling) in the putative RPE cells from rosettes (Figure 1B). 
In immunostaining, polygonal pigmented cells from rosettes which 
had been maintained as adherent culture for 45 days expressed both 
the transcription factor Mitf and the RPE-associated tight junction 
protein ZO-1 (Figure 1C). Control antibody showed no staining (data 
not shown). 
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Rosette (N2bF,d5)
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Figure 1. Confirmation of the putative retinal pigment epithelial cells (RPE cells) differentiated from human embryonic stem cell. (A) Pigment-
ed cells transferred on a cover glass on day 24 formed a monolayer structure and showed hexagonal shape on phase-contrast image. (B) Ex-
pression of the RPE molecular markers detected by reverse transcription-polymerase chain reaction. (C) Immunostaining showed the expres-
sion of Mitf (early RPE cell marker) and ZO-1 (RPE associated tight junction protein). Scale bars: (A) 50 µm; (C) 25 µm. GAPDH, glyceraldehydes-
3-phosphate dehydrogenase; DAPI, 4’6-diamidino-2-phenylindole. 
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2. Survival and localization of the putative RPE cells after 
subretinal implantation in a rat retinal degeneration model 
Hematoxylin and eosin staining of retinal section from sodium io-
date injected rat enucleated one week after implantation show ed 
transscleral injection site, surrounding retinal detachment, and cells 
with layer strucutre in the subretinal space (Figure 2). Subretinal cells 
were only visible posterior to the puncture site and were thought to 
be implanted putative RPE cells. The survival and the localization of 
the transplanted cells were confirmed by immunohistochemistry. 
Confocal microscopy showed the integration of DAPI-labeled cells in 
the subretinal space. They formed a layer and expressed mature RPE 
markers including bestrophin, RPE65, and ZO-1 at 1, 2, and 4 weeks 
after cell transplantation (Figure 3). 
Discussion
A major issue in any cell-based therapy is provision of a cell source 
that is readily available, safe, and can be developed commercially in 
Figure 2. Retinal sections obtained one week after transplantation (H&E stain). (A) Transplanted cells in subretinal space between outer nuclear 
layer (ONL) and degenerative retinal pigment epithelium (RPE) was visible posterior to the trans-scleral puncture site (arrow). (B) High-power 
image of outlined area in Figure 2A. Scale bars: (A) 200 µm; (B) 50 µm. V, vitreous cavity; A, anterior; P, posterior; IPL, internal plexiform layer; INL, 
internal nuclear layer; ONL, outer nuclear layer; T, transplanted putative retinal pigment epithelium cells.
A B
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Figure 3. Confocal microscopy showed the expression of mature retinal pigment epithelium (RPE) markers within the subretinal space at four 
weeks after transplantation. (A) Expression of RPE65. (B) Expression of bestrophin. Scale bars: (A) 25 µm; (B) 25 µm. DAPI, 4’6-diamidino-2-phe-
nylindole.
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large-scale production. On those points, there are numerous advan-
tages of using hESC-derived cells as a source for clinical studies. In 
addition, hESCs have high plasticity and migrating abilities compared 
to adult stem cells. In other regions of the central nervous system, 
the transplantation of neurons derived from ESC has led to some 
promising results. Dopaminergic neurons derived from mouse, mon-
key, and human ESC have been shown to integrate into the brain af-
ter transplantation and partially restore function in animal models of 
Parkinson’s disease [18-22]. Although hESCs have many advantages 
as mentioned above, they have some limitations at the same time, 
including ethical issues and teratoma risks. However, the chief prob-
lem is that we are still struggling to understand the developmental 
cues that differentiate hESCs into the specific retinal cell types requir-
ed for repair of damaged tissues.
It is worth noting that photoreceptor replacement is theoretically 
more straightforward than other retinal neurons because it is a sen-
sory neuron connected in only one direction and does not require 
complex dendritic synapses to generate afferent inputs. However, 
evidence is still lacking for producing fully functional photoreceptor 
cells needed for retinal repair, although researchers have made prog-
ress in understanding the developmental stimuli that derive retinal 
neurons and photoreceptor progenitors from mouse or human ESCs 
in vitro [23]. Instead, RPE cells derived from hESCs would be another 
candidate for transplantation. Since Klimanskaya et al. [11] first re-
ported the differentiation of RPE cells from hESC, several reports have 
described the potential of hESCs to differentiate into RPE cells in vitro 
[10-14]. In addition, subretinal transplantation of hESC-derived RPE 
cells in animal model preserved visual function and photoreceptor 
integrity [6,15,16]. As RPE cells do not require synaptic reconnection, 
RPE transplantation may be less complex than photoreceptors and 
retinal neurons.
The putative RPE cells derived from the hESC line SNUhES3 was well-
characterized here and satisfied many of the known criteria of RPE 
cells, including morphology, cellular pigmentation, and expression of 
markers associated with RPE fate. These properties were similar to 
those observed in cultured hESC-derived RPE, although we did not 
included functional analysis of hESC-derived RPE cells like in vitro 
phagocytosis assays [6,10-12]. As an exploration for another protocol 
to differentiate RPE cells, further investigation is in progress by our 
group to generate RPE cells from hESC-derived spherical neural mass-
es (SNMs) which we derived from EBs as described previously [18,24].
For implantation of cells, we used trans-scleral subretinal injection 
in this study. This method places the grafted cells closer to their in-
tended location than other approaches, but it is more complex and 
technically demanding. On the other hand, intravitreal injection is 
less invasive and easier, but grafted cells must migrate from the vitre-
ous cavity to the outer retina. Although there are conflicting results 
on the superiority of transplantation methods, subretinal injection is 
thought to be more physiologic if it were not for severe complication 
like intraocular hemorrhage or massive retinal detachment and is 
preferred by more researchers than intravitreal injection [25-27]. 
There are some points to improve the feasibility of the clinical ap-
plication of cell-based therapy in retinal degenerative diseases. The 
assessment of photoreceptor rescue or visual function recovery after 
hESC-RPE cell transplantation could be achievable with electrophysi-
ological evaluation using electroretinogram or behavioral test for vi-
sual function [28,29]. In addition, subretinal transplantation of differ-
entiated RPE cells in dystrophic Royal College of Surgeon (RCS) rat in-
stead of sodium iodate-induced degeneration model would provide 
more solid evidence of the therapeutic effect of cell transplantation. 
The RCS rat is a well-characterized model of retinal dystrophy in which 
the primary defect originating in RPE cells leads to blindness as a con-
sequent of photoreceptor degeneration [30].
In conclusion, we could differentiate pigmented cells from hESC 
under well-defined and reproducible conditions. The putative RPE 
cells showed characteristic morphologic features of the RPE cells and 
expressed molecular markers associated with RPE fate. We transplant-
ed these hESC-RPE cells in the subretinal space of rat retinal degener-
ation model, and the grafted cells were found to survive and inte-
grate within recipient retina up to four weeks after transplantation. 
Although there are still numerous unanswered questions surround-
ing stem cell transplantation in retinal degenerative diseases, these 
results support the feasibility of the hESC-derived RPE cells for cell-
based retinal therapies. 
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